Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“The future of breast cancer therapy is tied to the idea of individualizing treatment for each patient,” says Sara Tolaney, MD, MPH.
Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.
The new trials compare the two approaches to treating women with early-stage breast cancer with long-term follow-up.
Tafinlar (dabrafeb) plus Mekinist (trametinib) shrank tumors in people with biliary tract cancer and adenocarcinoma of the small intestine.
They are geared to the 10 to 15 percent of people with endometrial cancer who are diagnosed with an advanced stage of the disease.
Clinical trials are testing gel forms of oral drugs to help prevent the disease in women at an increased risk.
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
Ask your medical team about available trials, and consult the following list to get started.
Winter 2019 Survey
Researchers were able to preserve trial participants’ mental functions by avoiding the hippocampus during radiation treatment.
The drug, a PARP inhibitor, blocks proteins that help repair damaged DNA, and so can cause tumor cells that carry a BRCA mutation to die.
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.
Salvage radiation therapy is now higher on my list of options to consider, but I’m still concerned about potential long-term side effects.
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
The trial will soon have nearly 40 study arms testing different targeted therapies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.